IP vs LAB
International Paper (IP) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. LAB currently screens at market cap $317.1M.
Not investment advice. Open the IP and LAB stock pages for the full models.
Not investment advice.